Parenteral nutrition or total parenteral nutrition is defined as intravenous infusion of nutrition solutions to patients. Parenteral nutrition is administered in cases where the GI tract is leaking or not functioning, is inaccessible or adequate nourishment from by enteral or oral means is not accomplished. The commercially available premixed solutions adequately provide nutrition for short periods, however for complex patients, it is ideal to adopt a flexible system for personalizing parenteral nutrition. Parenteral nutrition is a complex therapeutic area and should be administered with precise clinical guidance. This report analyzes the commercial prospects for parenteral nutrition products.

For the purpose of this report, the global clinical nutrition market is segmented based on nutrient types and geographical distribution. The parenteral nutrients studied in this report include carbohydrates, amino acids, lipids, electrolytes and others (multivitamin formulations and trace elements). Market size and forecast for the period 2014-2023 along with respective CAGRs for the period 2016-2023 are presented for the considered segments.

The market size and forecast for the period 2014-2023 along with the CAGRs for the period 2016-2023 for the mentioned segments are presented in this study. Market size and forecast for nutrients segments for individual country-level markets are also provided in this report.

Qualitative information sets such as market dynamics (drivers, challenges, future prospects) and market inclination insights are provided in this market assessment report. Tools such as competition assessment and attractive investment proposition are also included for studying the competition in parenteral nutrition market. The report concludes with company profiles section that highlights key information about the major market players operating in the global parenteral nutrition market.

Nutrients Segmentation Investigation

Glucose is the most preferred carbohydrate energy source in parenteral nutrition. Lipids offer additional energy source and essential fatty acids. In parenteral nutrition solutions, lipids are emulsions of triglycerides and phospholipids. Lipids are administered separately or as a part of 3 in 1 parenteral nutrition system. Additionally, micronutrients are to be administered daily to the PN patient. Some commercially available PN bags already contain micronutrients whereas some administrations require separate addition. There are a number of trace elements, vitamins and other micronutrients solutions in the market, both as a single ingredient or as multiple ingredient preparation. Vitamins and trace elements are administered daily to parenteral nutrition patients in specified amounts as recommended. Products commercially available provide balanced trace elements additives and products are also available that provide IV vitamin with recommended daily requirement of fat- and water-soluble vitamins. Some micronutrients such as Vitamin K need to be administered as an additive.

The global parenteral nutrition market is currently led by North America and Europe. United States is the largest country level market for parenteral nutrition. Reimbursement plays a critical role in creating dominance of these regions on the global front. Moreover, high prevalence of chronic diseases in North America and Western Europe also critically contribute to the large market size. Asia-Pacific and Middle East and Africa are the fastest progressing markets for parenteral nutrition. High prevalence of malnutrition, growing numbers of premature births and huge geriatric population in Asia are the key drivers of growth in Asia-Pacific and Middle East and North Africa parenteral nutrition market. Based on these phenomena, the market players are increasingly focusing their growth strategies towards establishing their foothold in middle- and low-income markets through direct sales, and collaborations with government and non-government organizations.

Historical & Forecast Period

This study report represents analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Parenteral Nutrition market are as follows:

• Research and development budgets of manufacturers and government spending
• Revenues of key companies in the market segment
• Number of end users and consumption volume, price and value.
• Geographical revenues generate by countries considered in the report
• Micro and macro environment factors that are currently influencing the Parenteral Nutrition market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Key questions answered in this report

• What are the key micro and macro environmental factors that are impacting the growth of Parenteral Nutrition market?
• What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
• Estimated forecast and market projections up to 2032.
• Which segment accounts for the fastest CAGR during the forecast period?
• Which market segment holds a larger market share and why?
• Are low and middle-income economies investing in the Parenteral Nutrition market?
• Which is the largest regional market for Parenteral Nutrition market?
• What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
• Which are the key trends driving Parenteral Nutrition market growth?
• Who are the key competitors and what are their key strategies to enhance their market presence in the Parenteral Nutrition market worldwide?